Beneficial effects of ginkgetin on improving nonalcoholic steatohepatitis characterized by bulk and single-cell RNA sequencing analysis

Background and aims: Nonalcoholic steatohepatitis (NASH) has become one of the major causes of cirrhosis and liver failure. However, there are currently no approved medications for managing NASH. Our study was designed to assess the effects of ginkgetin on NASH and the involved mechanisms. Methods:...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chaoyang, Bai, Yaowei, Li, Tongqiang, Liu, Jiacheng, Wang, Yingliang, Ju, Shuguang, Yao, Wei, Xiong, Bin, Zhou, Guofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582714/
https://www.ncbi.nlm.nih.gov/pubmed/37860111
http://dx.doi.org/10.3389/fphar.2023.1267445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582714/
https://www.ncbi.nlm.nih.gov/pubmed/37860111
http://dx.doi.org/10.3389/fphar.2023.1267445

Ejemplares similares